Want to take quizzes and track your credits?
Sign in to take quiz and track your certificates
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Accepted for Publication: July 26, 2021.
Published: August 27, 2021. doi:10.1001/jamanetworkopen.2021.26931
Correction: This article was corrected on October 1, 2021, to fix errors in the Results, Discussion, and Table.
Open Access: This is an open access article distributed under the terms of the CC-BY-NC-ND License. © 2021 Harmon A et al. JAMA Network Open.
Corresponding Author: Laura E. Holberger, PhD, BioLabs (BioInnovation Labs, LLC), 139 Main St, 4th Floor, Cambridge, MA 01239 (email@example.com).
Author Contributions: Drs Holberger and Bosch had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Mr Harmon and Ms Chang contributed equally as co–first authors.
Concept and design: Harmon, Chang, Sena, Herrera, Bosch, Holberger.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Salcedo, Sena, Herrera, Bosch, Holberger.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Harmon, Salcedo, Herrera, Bosch, Holberger.
Obtained funding: Chang, Bosch, Holberger.
Administrative, technical, or material support: Chang, Sena, Bosch, Holberger.
Supervision: Chang, Sena, Herrera, Bosch, Holberger.
Conflict of Interest Disclosures: Ms Salcedo, Ms Sena, and Dr Herrera are employed by and have a financial interest in E25Bio, Inc, a biotechnology company that develops rapid tests for infectious diseases. At the time of the study, Mr Harmon and Dr Bosch were employed by E25Bio, Inc, and have a financial interest in the company. No other disclosures were reported.
Funding/Support: Funding was provided by E25Bio, Inc, LabCentral, Inc, and BioLabs, LLC, in 3 equal parts.
Role of the Funder/Sponsor: The 3 funding entities formed the Cambridge Consortium for Rapid COVID-19 Tests and were each involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: We thank all the participants in the study. Elena Naumova, PhD (Tufts University), assisted with the statistical analysis for this manuscript. Nikhil Lal, MEng (E25Bio, Inc), developed the digital platform. Adam R. Gomez, MS (E25Bio, Inc), and Dimitris P. Papageorgiou, PhD (E25Bio, Inc), assisted with data collection. Johannes Fruehauf, MD, PhD (BioLabs, LLC, and LabCentral, Inc), Sina Hoche, MA (Harvard University), and Prerna Sekhri, MS (LabCentral, Inc), assisted with study design. Sally Aubrey, BA (LabCentral, Inc), assisted with study execution. None of these individuals was compensated beyond their normal salaries.
Additional Information: LabCentral, Inc, donated operational support, laboratory space, and equipment for this work. BioLabs, LLC, and E25Bio, Inc, donated oversight and scientist time. Integra Biosciences, Scismic, and BioIT each contributed equipment or services.
You currently have no searches saved.